A Pilot Open Randomized Trial of Valproate and Phenobarbital in the Treatment of Acute Alcohol Withdrawal

References

• Brownell K. D., Marlatt G. A., Lichtenstein E., et al. Understanding and preventing relapse. Am Psychol 1986; 41: 765–782
   PubMed Web of Science ®Google Scholar
• McMahon R. C., Davidson R. S. Patterns of stability and change in mood states of alcoholics in inpa-tient treatment. International Journal of Addictions 1986; 21: 923–927
   PubMed Web of Science ®Google Scholar
• Marlatt G. A., Gordon J. R. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. Guilford, New York 1985
   Google Scholar
• Schuckit M. A., Hesselbrock V. M. Alcohol dependence and anxiety disorders: what is the relationship. Am J Psychiatry 1994; 151: 1723–1734
   PubMed Web of Science ®Google Scholar
• Weiss K. J., Rosenberg D. J. Prevalance of anxiety disorder among alcoholics. J Clin Psychiatry 1985; 46: 3–5
   PubMed Web of Science ®Google Scholar
• Schuckit M. A. Anxiety disorders and substance abuse. American Psychiatric Press Review of Psychiatry, A. Tasman, M. Riba. American Psychiatric Press, Washington, DC 1992; vol 11: 402–407, chapter 20
   Google Scholar
• Nutt D., Adinoff B., Linnoila M. Benzodiazepines in the treatment of alcoholism. Recent Dev Alcohol 1989; 7: 283–313
   Google Scholar
• Keck P. E., McElroy S. L., Friedman L. M. Valproate and carbamazepine in the treatment of panic and post-traumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psycho-pharmacol 1992; 12: 36S–41S
   PubMed Web of Science ®Google Scholar
• Roy-Byrne P. P., Ward N. G., Donnelly P. J. Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry 1989; 50(suppl)44–48
   PubMedGoogle Scholar
• Flygenring J., Hansen J., Hoist B., et al. Treatment of alcohol withdrawal symptoms in hospitalized patients: a randomized, double-blind comparison of carbamazepine (Tegretol) and barbital (Diemal). Acta Psychiatr Scand 1984; 69: 398–408
   PubMed Web of Science ®Google Scholar
• Agricola R., Mazzarino M., Urani R. Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with with tiapride. J Int Med Res 1982; 10: 160–165
   PubMed Web of Science ®Google Scholar
• Ritola E., Malinen L. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiatr Scand 1981; 64: 254–259
   PubMed Web of Science ®Google Scholar
• Malcolm R., Ballenger J. C., Sturgis E. T., et al. Double-lilinil controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrwawal. Am.J Psychiatry 1989; 146: 617–621
   PubMed Web of Science ®Google Scholar
• Hillbom M., Tokola R., Kuusela V., et al. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Alcohol (Eng) 1989; 6: 223–226
   PubMed Web of Science ®Google Scholar
• Anton R. F., Kranzler H. R., McEvoy J. P., et al. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Psychopharmacology (Berl) 1997; 131: 123–129
   Google Scholar
• Loscher W., Honack D. Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil. Naunyn Schmiedebergs Arch Pharmacol 1992; 345: 452–460
   Google Scholar
• Hillbom M. E. The prevention of ethanol withdrawal seizures in rats by dipropylacetate. Neu-ropharmacology 1975; 14: 755–761
   Google Scholar
• Noble E. P., Gillies R., Vigran R., et al. The modification of the ethanol wihdrawal syndrome in rats by di-n-propyl acetate. Psychopharmacologia 1976; 46: 127–131
   Google Scholar
• Lambie D. G., Johnson R. H., Vijayasenan M. E., et al. Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust N Z J Psychiatry 1980; 14: 213–215
   PubMed Web of Science ®Google Scholar
• Penry J. K. Monotherapy of primary generalized seizures. Diagnosis and Management of Epilepsy. Biomedical Information Corporation, New York 1986; 9–15
   Google Scholar
• Hammer B. A., Brady K. T. Valproate treatment of alcohol withdrawal and mania. Am J Psychiatry 1996; 9: 1232
   Google Scholar
• Allen A. M., Harris R. A. Involvement of neuronal chloride channels in ethanol intoxication, tolerance and dependence, in Recent Developments in Alcoholism, M. Galanter. Plenum, New York 1986; 313–325
   Google Scholar
• Mihic S. J., Harris R. A. GABA and the GABAArecep-tor. Alcohol Health & Research World 1997; 21: 127–131
   Google Scholar
• Tran V. T., Snyder S. H., Major L. F., et al. GABA receptors are increased in brains of alcoholics. Ann Neurol 1981; 9: 189–192
   Google Scholar
• Petty F., Sherman A. D. Plasma GABA levels in psychiatric illness. J Affect Dis 1984; 6: 131–138
   PubMed Web of Science ®Google Scholar
• Finn D. A., Crabbe J. C. Exploring alcohol withdrawal syndrome. Alcohol Health & Research World 1997; 21: 149–156
   Google Scholar
• Wilbur R., Kulik F. A. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anti-convulsants. American Journal of Hospital Pharmacy 1981; 38: 1138–1143
   Google Scholar
• Klotz U., Rapp T., Müller W. A. Disposition of val-proic acid in patients with liver disease. European Journal of Clinical Pharmacology 1978; 13: 55–60
   Google Scholar
• Hillbom M. E., Hjelm-Jager M. Should alcohol withdrawal seizures be treated with anti-epileptic drugs?. Acta Neurol Scand 1984; 69: 39–42
   PubMed Web of Science ®Google Scholar
• Rosenfeld W. E., Leppik I. E., Gates J. R., et al. Valproic acid loading during intensive monitoring. Arch Neurol 1987; 44: 709–710
   Google Scholar
• Becker H. C., Hale R. L. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal kindling. Alcoholism Clin Exp Res 1993; 17: 94–98
   Google Scholar
• Brown M. E., Anton R. F., Malcolm R., et al. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry 1988; 23: 507–514
   PubMed Web of Science ®Google Scholar
• Gross M. M., Lewis E., Nagarajan M. An improved quantitative system for assessing the acute alcohol psychoses and related states (TSA and SSA). Alcohol Intoxication and Withdrawal: Experimental Studies, Advances in Experimental Medicine and Biology, M. M. Gross. Plenum, New York 1973; vol. 35: 365–376
   Google Scholar
• Benzer D. G. Quantification of the alcohol with-drawal syndrome in 487 alcoholic patients. Journal of Substance Abuse Treatment 1990; 7: 117–123
   PubMed Web of Science ®Google Scholar
• Schmauss C., Apelt S., Emrich H. M. Characterization of benzodiazepine withdrawal in high-anil low-dose dependent psychiatric inpatients. Brain Res Bull 1987; 19: 393–400
   PubMed Web of Science ®Google Scholar
• McNair P. M., Lorr M., Droppleman L. F. POMS Manual2nd Edition. Education and Industrial Testing Service, San Diego, CA 1981
   Google Scholar
• Shacham S. A shortened version of the Profile of Mood States. J Pers Assess 1983; 47: 305–306
   PubMed Web of Science ®Google Scholar
• Buss A. H., Durkee A. An inventory for assessing different kinds of hostility. J Consult Clin Psychol 1957; 4: 343–349
   Google Scholar
• Schill T., Ramanaiah N., Conn S. R. Development of covert and overt hostility scales from the Buss-Durkee Inventory. Psychol Rep 1990; 67: 671–674
   Google Scholar
• SYSTAT: Statistics, Version 5.2.1 Edition. SYSTAT Inc., Evans-ton, IL 1992
   Google Scholar
• Brady K. T., Sonne S. C., Anton R., et al. Valproate in the treatment of acute bipolar affective disorders complicated by substance abuse: a pilot study. J Clin Psychiatry 1995; 56: 118–121
   PubMed Web of Science ®Google Scholar
• Minuk G. Y., Rockman G. E., German G. B., et al. The use of sodium valproate in the treatment of alcoholism. J Addict Dis 1995; 14: 67–74
   PubMed Web of Science ®Google Scholar